BBOT vs. VIR

Last updated Jun 3, 2026

BBOT (BridgeBio Oncology Therapeutics, Inc) and VIR (Vir Biotechnology, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.23 correlation, their price movements are largely independent.

Performance

BBOT vs. VIR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BridgeBio Oncology Therapeutics, Inc (BBOT) and Vir Biotechnology, Inc. (VIR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBOT achieves a -33.95% return, which is significantly lower than VIR's 45.44% return.

BBOT

• 1D: -3.27%
• 1M: -1.43%
• YTD: -33.95%
• 6M: -27.14%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

VIR

• 1D: 0.34%
• 1M: -13.85%
• YTD: 45.44%
• 6M: 39.87%
• 1Y: 67.69%
• 3Y*: -31.50%
• 5Y*: -27.88%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBOT vs. VIR - Yearly Performance Comparison

	2026 (YTD)	2025
BBOT BridgeBio Oncology Therapeutics, Inc	-33.95%	29.74%
VIR Vir Biotechnology, Inc.	45.44%	38.46%

Correlation

The correlation between BBOT and VIR is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Aug 13, 2025	0.23

Fundamentals

Market Cap BBOT : $661.86M VIR : $1.29B
EPS BBOT : -$3.90 VIR : -$3.14
Total Revenue (TTM) BBOT : $0.00 VIR : $65.50M
Gross Profit (TTM) BBOT : -$194.00K VIR : $183.11M
EBITDA (TTM) BBOT : -$168.31M VIR : -$448.10M

Return for Risk

BBOT vs. VIR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VIR

VIR Risk / Return Rank: 73
VIR Sharpe Ratio Rank: 71
VIR Sortino Ratio Rank: 72
VIR Omega Ratio Rank: 68
VIR Calmar Ratio Rank: 78
VIR Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBOT vs. VIR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BridgeBio Oncology Therapeutics, Inc (BBOT) and Vir Biotechnology, Inc. (VIR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	BBOT	VIR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.98	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.38	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.25	-0.07	-0.18

Drawdowns

BBOT vs. VIR - Drawdown Comparison

The maximum BBOT drawdown since its inception was -44.21%, smaller than the maximum VIR drawdown of -94.85%. Use the drawdown chart below to compare losses from any high point for BBOT and VIR.

Drawdown Indicators

	BBOT	VIR	Difference
Max Drawdown Largest peak-to-trough decline	-44.21%	-94.85%	+50.64%
Max Drawdown (1Y) Largest decline over 1 year	—	-27.82%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-84.10%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-92.15%	—
Current Drawdown Current decline from peak	-39.77%	-89.44%	+49.67%
Average Drawdown Average peak-to-trough decline	-18.98%	-67.57%	+48.59%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	11.31%	—

Volatility

Volatility by Period

	BBOT	VIR	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	15.95%	—
Volatility (6M) Calculated over the trailing 6-month period	—	50.16%	—
Volatility (1Y) Calculated over the trailing 1-year period	71.26%	69.20%	+2.06%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	71.26%	72.76%	-1.50%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	71.26%	96.10%	-24.84%

Dividends

BBOT vs. VIR - Dividend Comparison

Neither BBOT nor VIR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both BBOT and VIR in my portfolio?

BBOT and VIR have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.